Expression of interleukin-18 in murine contact hypersensitivity

Journal of Interferon and Cytokine Research

Volumn 18, Issue 9, 1998, Pages 653-659

  Xu, Baohui ^a   Aoyama, Kohji ^a   Yu, Su ^a   Kitani, Atsushi ^a   Okamura, Haruki ^b   Kurimoto, Masashi ^c   Matsuyama, Takami ^a   Matsushita, Toshio ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HYOGO COLLEGE OF MEDICINE   (Japan)

^c HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; CYTOKINE; INTERLEUKIN 18; OXAZOLONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ARTICLE; CELL DIFFERENTIATION; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; DRUG INDUCED DISEASE; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALIA; MURINAE;

EID: 0031720136     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.653     Document Type: Article

References (40)

1. MOSSAMANN, T.R., and HOFFMAN, R.L. (1989). Different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7, 145-173.
2. ASADA, H., LINTON, J., and KATZ, S.I. (1997). Cytokine gene expression during the elicitation phase of contact sensitivity: regulation by endogenous IL-4. J. Invest. Dermatol. 108, 406-411.
3. + T lymphocyte clones from nickel contact allergic and nonallergic individuals. J. Invest. Dermatol. 98, 59-63.
4. POWRIE, F., MENON, S., and COFFMAN, R.L. (1993). Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23, 3043-3049.
5. ABBAS, A.K., MURPHV, K.M., and SHER, A. (1996). Functional diversity of helper T lymphocytes. Nature 383, 787-793.
6. XU, B.H., AOYAMA, K., KITANI, A., MATSUYAMA, T., and MATSUSHITA, T. (1996). RT-PCR analysis of in vivo cytokine profiles in murine allergic contact dermatitis to DNCB. Toxicol. Methods 6, 23-31.
7. XU, B.H., AOYAMA, K., KITANI, A., MATSUYAMA, T., and MATSUSHITA, T. (1997). Expression of cytokine mRNAs in the draining lymph nodes following contact sensitivity in mice. Toxicol. Methods 7, 137-148.
8. MULLER, G., SALOGA, J., GERMANN, T., SCHULER, G., KNOP, J., and ENK, A.H. (1995). IL-12 as mediator and adjuvant for the induction of contact sensitivity in vivo. J. Immunol. 155, 4661-4668.
9. RIEMANN, H., SCHWARZ, A., GRABBE, S., ARAGANE, Y., LUGER, T.A., WYSOCKA, M., KUBIN, M., TRINCHIERI, G., and SCHWARZ, T. (1996). Neutralization of IL-12 in vivo prevents induction of contact hypersensitivity and inducs hapten-specific tolerance. J. Immunol. 156, 1799-1803.
10. + T cell development from regulatory T helper to effector T helper cells alters the contact hypersensitivity response. Eur. J. Immunol. 26, 2606-2612.
11. XU, B.H., AOYAMA, K., KITANI, A., YU, S., MATSUYAMA, T., and MATSUSHITA, T. (1998). Interleukin-12 enhances contact hypersensitivity by modulating the in vivo cytokine pattern in mice. J. Interferon Cytokine Res. 18, 23-31.
12. OKAMURA, H., TSUTSI, H., HOMATSU, T., YUTSUDO, M., HAKURA, A., TANIMOTO, T., TORIGOE, K., OKURA, T., NUKADA, Y., HATTORI, K., AKITA, K., NAMNA, M., TANABE, F., KONISHI, K., FUKUDA, S., and KURIMOTO, M. (1995). Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378, 88-91.
13. HUNTER, C.A., TIMANS, J., PISACANE, P., MENON, S., CAI, G., WALKER, W., ASTE-AMEZAGA, M., CHIZZONITE, R., BAZAN, J.F., and KASTELEIN, R.A. (1997). Comparison of the effects of interleukin-1 alpha, interleukin-1 beta and interferon-gamma-inducing factor on the production of interferon-gamma by natural killer. Eur. J. Immunol. 27, 2787-2792.
14. YOSHIMOTO, T., OKAMURA, H., TAGAWA, Y., IWAKURA, Y., and NAKANISHI, K. (1997). Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA 94, 3948-3953.
15. GHAYUR, T., BANERJEE, S., HUGUNIN, M., BUTLER, D., HERZOG, L., CARTER, A., QUINTAL, L., SEKUT, L., TALANIAN, R., PASKIND, M., WONG, W., KAMEN, R., TRACEY, D., and ALLEN, H. (1997). Caspase-1 processes IFN-gamma-inducing factor and regulates LPS-induced IFN-gamma production. Nature 386, 619-623.
16. ROTHE, H., HIBINO, T., ITOH, Y., KOLB, H., and MARTIN, S. (1997). Systemic production of interferon-gamma inducing factor (IGIF) versus local IFN-gamma expression involved in the development of Th1 insulitis in NOD mice. J. Autoimmun. 10, 251-256.
17. ROTHE, H., JENKINS, N.A., COPELAND, N.G., and KOLB, H. (1997). Active stage of autoimmune diabetes is associated with the expression of a novel cytokine, IGIF, which is located near Idd2. J. Clin. Invest. 99, 469-474.
18. STOLL, S., MULLER, G., KURIMOTO, M., SALOGA, J., TANIMOTO, T., YAMAUCHI, H., OKAMURA, H., KNOP, J., and ENK, A.H. (1997). Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes. J. Immunol. 159, 298-302.
19. CHOMCZYNSKI, P., and SACCHI, N. (1987). Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
20. SCHAD, A., FAHIMI, H.D., VOLKL, A., and BAUMGART, E. (1996). Nonradioactive in situ hybridization for detection of mRNAs encoding for peroxisomal proteins: heterogeneous hepatic lobular distribution after treatment with a single dose of bezafibrate. J. Histochem. Cytochem. 44, 825-834.
21. + T cells but induces type I T cells in the liver by induction of IL-12 and IL-18 production from Kupffer cells. J. Immunol. 159, 97-106.
22. USHIO, S., NAMBA, M., OKURA, T., HATTORI, K., NUKADA, Y., AKITA, K., TANABE, F., KONISHI, K., MICALLEF, M., FUJII, M., TORIGOE, K., TANIMOTO, T., FUKUDA, S., IKEDA, M., OKAMURA, H., and KURIMOTO, M. (1996). Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156, 4274-4279.
23. UDAGAWA, N., HORWOOD, N.J., ELLIOTT, J., MACKAY, A., OWENS, J., OKAMURA, H., KURIMOTO, M., CHAMBERS, T.J., MARTIN, T.J., and GILLESPIE, M.T. (1997). Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation. J. Exp. Med. 185, 1005-1012.
24. TAKEUCHI, M., NISHIZAKI, Y., SANO, O., OHTA, T., IKEDA, M., and KURIMOTO, M. (1997). Immunohistochemical and immuno-electron-microscopic detection of interferon-gamma-inducing factor ("interleukin-18") in mouse intestinal epithelial cells. Cell Tissue Res. 289, 499-503.
25. MEYER ZUM BUSCHENFELDE, C., CRAMER, S., TRUMPFHELLER, C., FLEISCHER, B., and FROSCH, S. (1997). Trypanosoma cruzi induces strong IL-12 and IL-18 gene expression in vivo: correlation with interferon-gamma (IFN-gamma) production. Clin. Exp. Immunol. 110, 378-385.
26. CONTI, B., JAHNG, J.W., TINTI, C., SON, J.H., and JOH, T.H. (1997). Induction of interferon-gamma inducing factor in the adrenal cortex. J. Biol. Chem. 272, 2035-2037.
27. MICALLEF, M.J., OHTSUKI, T., KOHNO, K., TANABE, F., USHIO, S., NAMBA, M., TANIMOTO, T., TORIGOE, K., FUJII, M., IKEDA, M., FUKUDA, S., and KURIMOTO, M. (1996). Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26, 1647-1651.
28. MATSUMOTO, S., TSUJI-TAKAYAMA, K., AIZAWA, Y., KOIDE, K., TAKEUCHI, M., OHTA, T., and KURIMOTO, M. (1997). Interleukin-18 activates NF-kappaB in murine T helper type 1 cells. Biochem. Biophys. Res. Commun. 234, 454-457.
29. MORITA, H., HORI, M., and KITANO, Y. (1996). Modulation of picryl chloride-induced contact hypersensitivity reaction in mice by nitric oxide. J. Invest. Dermatol 107, 549-552.
30. ZHANG, T., KAWAKAMI, K., QURESHI, M.H., OKAMURA, H., KURIMOTO, M., and SAITO, A. (1997). Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65, 3594-3599.
31. + T cells. J. Exp. Med. 183, 1001-1012.
32. ENK, A.H., SALOGA, J., BECKER, D., MOHAMADZADEH, M., and KNOP, J. (1994). Induction of hapten-specific tolerance by interleukin 10 in vivo. J. Exp. Med. 179, 1397-1402.
33. ENK, A.H., ANGRLONI, V.L., UDEY, M.C., and KATZ, S.I. (1993). An essential role of Langerhans cell-derived IL-1 beta in the initiation of primary immune response in skin. J. Immunol. 150, 3698-3704.
34. LARSEN, M., THOMSEN, M.K., GESSER, B., THOMSEN, P.D., DELEURAN, B.W., NOWAK, J., SKODT, V., THOMSEN, H.K., DELEURAN, M., and THESTRUP-PEDERSE, K. (1995). The delayed-type hypersensitivity reaction is dependent on IL-8. Inhibition of a tuberculin skin reaction by an anti-IL-8 monoclonal antibody. J. Immunol. 155, 2151-2157.
35. + human blood mononuclear cells. J. Clin. Invest. 101, 711-721.
36. DAO, T., OHASHI, K., KAYANO, T., KURIMOTO, M., and OKAMURA, H. (1996). Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper I cells. Cell. Immunol. 173, 230-235.
37. OHTSUKI, T., MICALLEF, M.J., KOHNO, K., TANIMOTO, T., IKEDA, M., and KURIMOTO, M. (1997). Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res. 17, 3253-3258.
38. TSUTSUI, H., MATSUI, K., KAWADA, N., HYODO, Y., HAYASHI, N., OKAMURA, H., HIGASHINO, K., and NAKANISHI, K. (1997). IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J. Immunol. 159, 3961-3967.
39. WALDNER, H., SOBEL, R.A., HOWARD, E., and KUCHROO, V.K. (1997). Fas- and FasL-deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159, 3100-3103.
40. SABELKO, K.A., KELLY, K.A., NAHM, M.H., CROSS, A.H., and RUSSELL, J.H. (1997). Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159, 3096-3099.